Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, BriaCell Therapeutics Corp (NASDAQ: BCTX) closed at $2.97 up 3.12% from its previous closing price of $2.88. In other words, the price has increased by $3.12% from its previous closing price. On the day, 4.06 million shares were traded. BCTX stock price reached its highest trading level at $3.16 during the session, while it also had its lowest trading level at $2.825.
Ratios:
For a deeper understanding of BriaCell Therapeutics Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 14, 2022, initiated with a Buy rating and assigned the stock a target price of $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCTX now has a Market Capitalization of 20124988 and an Enterprise Value of 7190682.
Stock Price History:
The Beta on a monthly basis for BCTX is 1.31, which has changed by 1.6756756 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, BCTX has reached a high of $29.40, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is -19.17%, while the 200-Day Moving Average is calculated to be -59.05%.
Shares Statistics:
For the past three months, BCTX has traded an average of 1.43M shares per day and 511970 over the past ten days. A total of 6.56M shares are outstanding, with a floating share count of 6.34M. Insiders hold about 6.47% of the company’s shares, while institutions hold 3.67% stake in the company. Shares short for BCTX as of 1748563200 were 517532 with a Short Ratio of 0.36, compared to 1745971200 on 279390. Therefore, it implies a Short% of Shares Outstanding of 517532 and a Short% of Float of 7.8.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
